Ocean Pine Healthcare Fund
Oceanpine Healthcare Fund is a Beijing-based venture capital firm established in 2016, focusing on the healthcare sector. The fund aims to connect innovative healthcare solutions from the United States with the Chinese consumer market. It primarily invests in biotech, medical devices, innovative drug discovery, genome sequencing, in-vitro diagnostics, and artificial intelligence. By addressing the supply and demand gap in China, which is hindered by limited research and development, Oceanpine employs a "Dual Market" strategy to support its portfolio companies. This approach provides local resources and guidance, facilitating growth and development while offering investors diversification and enhanced value realization.
https://crunchbase.com/organization/***
1 past transactions
Refuge Biotechnologies
Series B in 2018
Refuge Biotechnologies, Inc. is a biotechnology company focused on developing innovative cancer immunotherapies. Founded in 2015 and based in Menlo Park, California, the company utilizes advanced gene-editing technology, specifically CRISPR-dCas, to create cell therapies that are capable of sensing their environment and conditionally regulating multiple genes at once. This approach enables Refuge to enhance the potency and specificity of its treatments, allowing for more effective targeting of cancer cells compared to traditional therapies that focus on a single target. Through its research and development efforts, Refuge aims to unlock the full potential of cell therapies in the fight against cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.